Workshops

Monday 07 May 15:45-17:00

Cholesterol and cellular lipid metabolism

Chair:
  • Bart Steals, France
  • Albert K. Groen, Netherlands

The role of bile acids in cholesterol homeostatis

Albert K. Groen, Groningen, The Netherlands

Lipid signaling pathways in physiology and disease

Peter Tontonoz, Los Angeles, USA


Sunday 06 May 11:30-12:45

Lipoprotein receptors - and regulation

Chair:
  • Giuseppe Danilo Norata, Italy
  • Geesje M Dallinga-Thie, Netherlands

PCSK9/LDLR axis in pancreatic function

Giuseppe Danilo Norata, Milan, Italy

Lipoprotein metabolism in the brain

Joachim Herz, Dallas, USA


Monday 07 May 11:30-12:45

Advanced research seminar: System medicine in cardiometabolic diseases

Chair:
  • Manuel Mayr, United Kingdom
  • Ruth Frikke-Schmidt, Denmark

Nonalcoholic liver hepatic steatosis: a systems biology approach

Adil Mardinoglu, Stockholm, Sweden

Systems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrix

Manuel Mayr, London, United Kingdom

The power of natural variation: mouse genetics and cardiovascular disease

Aldons J. Lusis, Los Angeles, USA


Sunday 06 May 15:45-17:00

Novel targets for dyslipidaemia and cardiovascular disease

Chair:
  • Sotirios (Sam) Tsimikas, USA
  • Ulrich Laufs, Germany

Nanomedicine as novel atherosclerosis thearpy

Willem J.M. Mulder, New York/ Amsterdam, USA / The Netherlands

Are we ready to test the Lp(a) hypothesis?

Sotirios (Sam) Tsimikas, San Diego, USA


Monday 07 May 11:30-12:45

Novel technologies for cardiovascular research

Chair:
  • Seppo Ylä-Herttuala, Finland
  • Lina Badimon, Spain

Potential and caveats of lipidomics for cardiovascular disease

Edward A. Dennis, San Diego, USA

Cardiovascular gene therapy

Seppo Ylä-Herttuala, Kuopio, Finland


Tuesday 08 May 11:30-12:45

Healthy food and lifestyle to prevent and treat atherometabolic diseases

Chair:
  • Emilio Ros, Spain
  • Erkin Mirrakhimov, Kyrgyzstan

Lessons from the "Prevention with mediterranean Diet" (Predimed) study

Emilio Ros, Barcelona, Spain

How to combat CVD at a population level?

Nick J. Wareham, Cambridge, United Kingdom


Sunday 06 May 11:30-12:45

Immune cell crosstalk in atherosclerosis

Chair:
  • Ziad Mallat, United Kingdom
  • Laurent Yvan-Charvet, France

Distant control of plaque formation

Filip K. Swirski, Boston, USA

Functional immune cell interactions and plaque development

Ziad Mallat, Cambridge, United Kingdom


Monday 07 May 15:45-17:00

Macrophages and foam-cells in the vessel wall

Chair:
  • Mark Febbraio, Australia
  • Katariina Öörni, Finland

Senescent intimal foam cells are deleterious at all stages of atherosclerosis

Jan M. van Deursen, Rochester, USA

Role of TLR4 in lipid induced macrophage inflammation

Mark Febbraio, Darlinghurst, Australia


Sunday 06 May 15:45-17:00

Role of endothelial and SMC cells in atherogenesis

Chair:
  • Michael Potente, Germany
  • Erik Biessen, Netherlands

Transcriptional control of endothelial energy

Michael Potente, Bad Nauheim, Germany

Vascular smooth muscle cells in atherosclerosis

Gary K. Owens, Charlottesville, USA


Tuesday 08 May 11:30-12:45

Molecular-cellular mechanisms that mediate vascular disease

Chair:
  • Alan Tall, USA
  • Patrick Rensen, Netherlands

The role of efferocytosis in atherosclerosis

Nicholas J. Leeper, Boston, USA

Clonal hematopoiesis in atherosclerosis

Alan Tall, New York, USA